Tooba Momen

Tooba Momen

Auto-generated profile, based on publicly available information

Tooba Momen

Department of Allergy and Clinical Immunology, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
Hassan AbolhassaniHassan Abolhassani
Hassan Abolhassani
JCJanet Chou
Janet Chou
WBWayne Bainter
Wayne Bainter
CPCraig D. Platt
Craig D. Platt
MTMahmood Tavassoli
Mahmood Tavassoli
AAAsghar Aghamohammadi
Asghar Aghamohammadi

1 January 2011 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
SASoheila Alyasin
Soheila Alyasin
TMTooba Momen
Tooba Momen
SKSara Kashef
Sara Kashef
AAAbbass Alipour
Abbass Alipour
RAReza Amin
Reza Amin
Alyasin S, et al. Allergy Asthma Immunol Res. 2011 Oct;3(4):251-255. http://dx.doi.org/10.4168/aair.2011.3.4.251

1 January 2017 in International Journal of Preventive Medicine
Verified
Journal Article
Open access
PDF file
TMTooba Momen
Tooba Momen
HAHamid Ahanchian
Hamid Ahanchian
MRMohsen Reisi
Mohsen Reisi
SSSeyedeh Azra Shamsdin
Seyedeh Azra Shamsdin
ASArmindokht Shahsanai
Armindokht Shahsanai
MKMajid Keivanfar
Majid Keivanfar
Background: The relation between interleukin-33 (IL-33) and asthma is not precisely known yet. The present study set to compare the serum level of IL-33 in patients with asthma and controls and study the relation with the severity of disease. Methods: The serum level of IL-33 and total IgE in 89 asthmatic patients and 57 controls were analyzed. The association of levels of IL-33 with the severity of disease, levels of total IgE, measures of spirometry (forced expiratory volume in 1 s [FEV1]), age, sex, presence or absence of other allergic diseases, and the disease duration was evaluated. Results: Higher levels of IL-33 and total IgE were detected in asthmatic patients compared with controls (P = 0.0001 and P = 0.008, respectively). In the asthmatic group, a significant direct association of IL-33 with age (P = 0.02, R = 0.23) and with total IgE level (P = 0.003, R = 0.31) were observed, but there was no relationship between other variables. Comparison of mean level of IL-33 in different asthma groups concerning the disease severity showed the statistically significant difference between them and a significant increased serum level of total IgE was observed in more severe disease. The results showed a significant negative correlation between FEV1 and total IgE (P = 0.028, R = −0.23) and IL-33 level (P = 0.0001, R = −0.83). Conclusions: IL-33 is suggested as a new inflammatory marker of severe and refractory asthma. Therefore, it may be a unique therapeutic target in these patients.

12 August 2021 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
AHAndreas Hüllen
Andreas Hüllen
KFKristina Falkenstein
Kristina Falkenstein
CWCorina Weigel
Corina Weigel
HHHidde Huidekoper
Hidde Huidekoper
NNNora Naumann‐Bartsch
Nora Naumann‐Bartsch
SWSaskia Brigitte Wortmann
Saskia Brigitte Wortmann

8 February 2022 in International Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
BABahareh Abtahi-Naeini
Bahareh Abtahi-Naeini
MDMohammad-Sadegh Dehghan
Mohammad-Sadegh Dehghan
FPFatemeh Paknazar
Fatemeh Paknazar
ZSZabihollah Shahmoradi
Zabihollah Shahmoradi
GFGita Faghihi
Gita Faghihi
TMTooba Momen
Tooba Momen
Background. Different epidemiologic aspects of drug-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in children are scarce. Aim. To compare the clinical and epidemiological features of patients with drug-induced SJS and TEN in children and adults. Method. This retrospective study was conducted at two academic referral centers (Isfahan, Iran) over 5 years. SJS and TEN were clinically diagnosed and confirmed by skin biopsy as needed. Results. One hundred one patients (31 children and 70 adults) with a female to male ratio of 1.1 : 1 was identified in the present study. SJS was more commonly diagnosed in both pediatric and adult patients. The most frequent reason for drug administration identified was the infection (45.2%) and seizure (45.2%) in children and infection (34.3%) and psychiatry disorder (27.1%) in adults ( ). The most common culprit drugs in the pediatric were phenobarbital (9/31), cotrimoxazole (4/31), and amoxicillin (4/31); however, in the adult group, the most common drugs were carbamazepine (11/70) and lamotrigine (9/70). Fever was significantly more common in adults (44.3%) compared to pediatric patients (22.6%) ( ). Multiple logistic regression models showed that pediatric patients had significantly lower odds of hospitalization (OR [odds ratio]: 0.14; 95% CI 0.02, 0.67). In addition, patients with SCORTEN 1 had significantly higher odds of hospitalization (OR: 6.3; 95% CI: 1.68, 23.79) compared to patients with SCORTEN 0. Conclusions. The present study showed several differences between the pediatric and adult patients with SJS and TEN, including the reason for drug administration, culprit drugs, length of hospital stay, presence of fever, and final diagnosis of disease.

1 November 2016 in Oman Medical Journal
Verified
Journal Article
Open access
TMTooba Momen
Tooba Momen
YMYahya Madihi
Yahya Madihi
Bullous systemic lupus erythematosus (BSLE) is an autoimmune blistering disease occurring in patients with systemic lupus erythematosus (SLE). It is a rare disease, especially in children. A 14-year-old girl initially presented with fatigue, generalized vesiculobullous skin lesions, and ulcers over the hard palate and oral mucosa. Clinical investigations revealed hematuria and proteinuria, a high erythrocyte sedimentation rate and titer of antinuclear antibody, and anti-double-stranded DNA. Skin biopsy findings were suggestive of BSLE. A renal biopsy confirmed the features of class V lupus nephritis. Based on the clinical features and investigations, a diagnosis of BSLE with nephritis was made. She received methylprednisolone pulse therapy and hydroxychloroquine; however, it did not alleviate the vesiculobullous eruption, so treatment with dapsone started and resulted in the dramatic disappearance of the lesions. Interruption of dapsone due to hemolysis did not aggravate the bullous disease. During follow-up, she had multiple flare-ups of disease and nephritis without rebound of bullous lesions. BSLE is a rare presentation of SLE in children. Differentiating it from other skin bullous diseases and SLE with blister is important for the correct management. The unusual presentation of this disease may delay the diagnosis and therefore requires a high index of clinical suspicion.